Hyundai Pharmaceutical Co., Ltd. logo

Hyundai Pharmaceutical Co., Ltd. (004310)

Market Open
3 Mar, 06:30
KRX SM KRX SM
11,470. 00
-450
-3.78%
311.54B Market Cap
- P/E Ratio
120% Div Yield
365,766 Volume
0 Eps
11,920
Previous Close
Day Range
11,310 11,790
Year Range
2,995 15,960
Want to track 004310 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

004310 trading today lower at ₩11,470, a decrease of 3.78% from yesterday's close, completing a monthly decrease of -10.39% or ₩1,330. Over the past 12 months, 004310 stock gained 34.62%.
004310 pays dividends to its shareholders, with the most recent payment made on 5 hours ago. The next estimated payment will be in 3 Mar 2027 on Mar 03, 2027 for a total of ₩30.
The last earnings report, released on Oct 15, 2013, exceeded the consensus estimates by 22%. On average, the company has surpassed earnings expectations by 22.39%, based on the last three reports.
Hyundai Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Oct 20, 2017.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

004310 Chart

Similar

Hyundai Motor Co.
643,000
-4.6%
Hyundai Motor Co. Ltd.
291,000
-5.06%
Hyundai Motor Co. Ltd. Preferred
302,500
-5.91%
Hyundai Motor Co., Ltd. Preferred
306,500
-5.26%
Kia Corporation
193,100
-6.03%

Hyundai Pharmaceutical Co., Ltd. (004310) FAQ

What is the stock price today?

The current price is ₩11,470.00.

On which exchange is it traded?

Hyundai Pharmaceutical Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 004310.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 120%.

What is its market cap?

As of today, the market cap is 311.54B.

Has Hyundai Pharmaceutical Co., Ltd. ever had a stock split?

Hyundai Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Oct 20, 2017.

Hyundai Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Sang-Jun Lee CEO
KRX SM Exchange
KR7004310009 ISIN
KR Country
- Employees
- Last Dividend
17 Mar 2008 Last Split
- IPO Date

Overview

Founded in 1965, Hyundai Pharmaceutical Co., Ltd. is a distinguished entity in the pharmaceutical industry, based in Seoul, South Korea. The company has carved a niche for itself both domestically and internationally by manufacturing and distributing a wide array of pharmaceutical products, health food drinks, and medical devices. Its commitment to improving health and enriching lives through innovative and effective products is evident in its diverse product range. Hyundai Pharmaceutical operates in the pharmaceutical sector with a keen focus on producing both ETC (Ethical Pharmaceutical Products) and OTC (Over The Counter) products across various therapeutic areas. Their mission encapsulates delivering health solutions that are not only accessible but also of the highest quality, catering to a spectrum of health needs and contributing to the global healthcare industry.

Products and Services

  • ETC and OTC Products in Various Therapeutic Areas:

    Hyundai Pharmaceutical specializes in a vast range of prescription (ETC) and over-the-counter (OTC) products focused on numerous therapeutic fields. These include cardiovascular health (antianginal, antihypertensive), infection control (antibiotic, antifungals), gastrointestinal health (digestive system, gastrointestinal disorder and digestant), reproductive health (oestrogens, systemic hormonal contraceptives), dermatology (dermatological agent, acne treatment), and nutritional supplements (vitamins, nutrition). Each product category is developed with precise formulations to address specific health concerns efficiently.

  • Health Food Drinks:

    The company offers a range of health food drinks aimed at enhancing overall health. These drinks are formulated with natural ingredients known for their health benefits, targeting areas such as immune system boosting, energy enhancement, and nutritional supplementation. Hyundai’s health beverages are designed not only to complement the consumer’s diet but also to support a healthy lifestyle.

  • Medical Devices:

    Hyundai Pharmaceutical extends its contribution to healthcare through the provision of medical devices. These devices cater to diverse medical needs, including diagnostic tools, health monitoring devices, and other therapeutic products. Each device is engineered with the latest technology to ensure reliability, accuracy, and ease of use, supporting both healthcare professionals and patients in managing health more effectively.

  • Comprehensive Therapeutic Solutions:

    The company’s portfolio spans a broad spectrum of therapeutic areas, offering solutions for anemia, alopecia treatment, allergy relief, analgesics, anti-inflammatory, antimicrobial, antiviral, arthritis care, contraceptives, dermatology, diagnostics, eye care, nutrition, respiratory care, wound healing, and more. Hyundai Pharmaceutical is committed to advancing healthcare through the development of products that cater to a wide range of medical conditions, aiming to improve the quality of life for patients around the globe.

Contact Information

Address: Hyundai Pharm Building, Seoul, South Korea, 06121
Phone: -